Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mueller, C. R.
Right arrow Articles by Stoppa-Lyonnet, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mueller, C. R.
Right arrow Articles by Stoppa-Lyonnet, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 European Society for Medical Oncology

External quality assessment for mutation detection in the BRCA1 and BRCA2 genes: EMQN's experience of 3 years

C. R. Mueller1,*, U. Kristoffersson2 and D. Stoppa-Lyonnet3

1 Department of Human Genetics, University of Wuerzburg, Germany; 2 Department of Clinical Genetics, University Hospital Lund, Sweden; 3 Oncogenetics Unit, Institut Curie, Paris, France

* Correspondence to: Dr C. R. Mueller, Department of Human Genetics, University of Wuerzburg, Biozentrum, Am Hubland, 97074 Wuerzburg, Germany. Tel: +49-931-888-4063; Fax: +49-931-888-4069; Email: crm{at}biozentrum.uni-wuerzburg.decorresponding

Abstract

Background: The European Molecular Genetics Quality Network (EMQN) was formed in order to improve external quality assessment for molecular genetic testing in Europe. From 1999 to 2002 it received funding from the European Union under the Standards, Measurement and Testing programme (contract no. SMT4-CT98-7515). Since then, its maintenance has been supported through subscription of the participants, and it has been coordinated by the National Genetic Reference Laboratory at Manchester, UK (Rob Elles and Simon Patton; www.emqn.org).

Materials and methods: Among other external quality assessment (EQA) schemes, EMQN has provided an EQA scheme for mutation detection in the breast cancer genes, BRCA1 and BRCA2, designed to cover the two important aspects of genetic testing: (i) genotyping and (ii) interpretation and reporting of results. The fourth full scheme was completed in 2003, with data evaluation pending for the 47 participants.

Results: Analysis of genotyping data has pinpointed two main types of errors: (i) missing a mutation (in nine of the 17 false results a normal sequence was reported); and (ii) description of the observed sequence change by an incorrect nomenclature. Compared with the more technical process of genotyping, the writing of reports displayed a much wider variation between laboratories.

Conclusions: From the reported data it is clear that external quality control should become an integral part of quality assessment in the laboratory, thus contributing to maintaining confidence in the reliability of genetic testing among patients and health professionals.

Key words: BRCA, genetic testing, quality control


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Clin. Chem.Home page
S. C. Ramsden, S. Daly, W.-J. Geilenkeuser, G. Duncan, F. Hermitte, E. Marubini, M. Neumaier, C. Orlando, V. Palicka, A. Paradiso, et al.
EQUAL-quant: An International External Quality Assessment Scheme for Real-Time PCR
Clin. Chem., August 1, 2006; 52(8): 1584 - 1591.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.